Centrify Integrates With Concur Travel & Expense to Deliver

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Centrify Integrates With Concur Travel & Expense to Deliver Single Sign-On and Mobile Management for Concur Users

SANTA CLARA, CA--(Marketwired - Jun 23, 2014) - Centrify Corporation, the leader in unified identity services across data center, cloud and mobile, today announced the integration of Centrify User Suite with Concur ® ( NASDAQ : CNQR ), the leading provider of spend management solutions and services. Centrify provides Concur clients with secure single sign-on (SSO) for Concur and delivers a simplified, integrated identity and mobile management infrastructure for IT organizations running Concur and other SaaS applications.

Through this partnership, Centrify is now included in the Concur App Center , which offers apps with streamlined integration with Concur Travel, Expense and Invoice products and delivers innovative functionality in key categories such as finance, regulatory compliance, enterprise identity, traveler productivity, travel management and more.

Centrify provides Concur users with the widest array of mobility features for an Identity-as-a-Service (IDaaS) offering, including secure SSO for the Concur rich mobile app, and mobile device management tools for both end users and IT -- including user self-service to enable end users to locate and wipe their own devices. Centrify provides IT organizations with centralized management and security by leveraging their on-premises Active Directory or using the Centrify cloud directory service -- and does not require customers to replicate their directory to a third party cloud service.

"We remain committed to growing our partner ecosystem featuring innovative solutions that meet the demands of the organization and their business travelers," said Jigish Avalani, GM and SVP of Platform and Developer Services for Concur. "We are pleased to be working with Centrify to make an integrated single sign-on solution available to our joint customers and prospects. With Centrify available in the Concur App Center, IT admins now have an easy way to enable secure SSO and mobile device management."

Centrify's solution goes well beyond Mobile Device Management (MDM) and SaaS single sign-on (SSO) to also provide comprehensive Mobile Application Management (MAM), Multi-Factor Authentication (MFA) and "zero sign-on" for browser-based applications and rich mobile applications, addressing the IT and user challenges surrounding "Bring Your Own Device" (BYOD) adoption and the explosion of cloud-based apps. As a result, Centrify delivers true mobile enablement for enterprise cloud and mobile environments.

"Centrify is pleased to provide a single sign-on solution for Concur clients that delivers a secure mobile management experience, and does not replicate customers' directories in our cloud," said Shreyas Sadalgi, Centrify VP of Business Development. "The integration between Concur and Centrify optimizes the end user experience and creates a simplified identity infrastructure for IT."

For more information and to access Centrify on the Concur App Center, see https://www.concur.com/en-us/app-center/listi...R/Centrify

About Centrify Centrify provides unified identity services across data center, cloud and mobile environments that result in single sign-on (SSO) for users and a simplified identity infrastructure for IT. Centrify's unified identity management software and cloud-based Identity-as-a-Service (IDaaS) solutions leverage an organization's existing identity infrastructure to enable single sign-on , multi-factor authentication, privileged identity management, auditing for compliance and mobile device management. Centrify customers can typically reduce their total cost of identity management and compliance by more than 50 percent, while improving business agility and overall security. Centrify is used by more than 5,000 customers worldwide, including approximately half of the Fortune 50 and more than 60 Federal agencies.

For more information, please visit http://www.centrify.com/

Centrify is a registered trademark and Centrify Server Suite and Centrify User Suite are trademarks of Centrify Corporation in the United States and other countries. All other trademarks are the property of their respective owners.

Media Contact: Jeff Seedman Email Contact (415) 249-6763 Analyst Contact: Dan Spalding Email Contact (408) 960-9297

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Market Expansion of Utility Solar Trackers: Future Insights

Updated Category News Views 247

Utility Solar Tracker Market Growth Prospects The utility solar tracker market is projected to reach an impressive USD 34.6 billion in the coming years. This growth is largely driven by the declining costs of photovoltaic (PV) panels, which have significantly lowered the financial barriers for solar energy projects. As PV panels become more affordable, the opportunity for...

Continue Reading
UVA Cancer Center Joins Caris Precision Oncology Alliance

Updated Category News Views 59

UVA Cancer Center Joins the Caris Precision Oncology Alliance UVA Cancer Center has officially joined the Caris Precision Oncology Alliance (Caris POA), a significant network dedicated to advancing precision medicine and cancer treatment. Caris Life Sciences is thrilled to welcome this esteemed institution, recognized for its commitment to enhancing patient outcomes...

Continue Reading
Investors Show Strong Confidence in Spotify Technology's Future Potential

Updated Category News Views 116

High-Rolling Investors Stake Their Bets on Spotify Technology In recent developments, it's evident that significant investors have adopted a bullish stance on Spotify Technology. This movement warrants attention from retail traders and those interested in stock market dynamics. Overview of Options Activity Tracking the latest trends, we've noted a remarkable surge in...

Continue Reading
Johnson & Johnson's Groundbreaking CAR T-Cell Therapy Data Unveiled

Updated Category News Views 191

Johnson & Johnson’s CAR T-Cell Therapy Demonstrates Promise in Lymphoma In a recent Phase 1b study, Johnson & Johnson (NYSE: JNJ) revealed the first clinical results of its investigational dual-targeting CAR T-cell therapy, JNJ-90014496, specifically aimed at treating patients with relapsed or refractory large B-cell lymphoma (R/R LBCL). This early data suggests a...

Continue Reading
Booking Holdings Prepares for Upcoming Earnings Report

Updated Category News Views 143

Booking Holdings Set for Earnings Announcement Booking Holdings (NASDAQ: BKNG) is gearing up to share its quarterly earnings. Investors are keenly awaiting this announcement, which is expected to be significant for market sentiment and share price movements. Expected Earnings Per Share According to analysts, Booking Holdings is projected to report an impressive earnings...

Continue Reading